Simon Segars - Dolby Laboratories Independent Director
| DLB Stock | USD 79.16 0.35 0.44% |
Director
Mr. Simon Segars serves as Independent Director of the Company. Since 1991, Mr. Segars has worked for ARM Holdings plc, a designer and provider of microprocessors, software development tools and related technologies that was publicly held until its acquisition by SoftBank Group Corporationration in September 2016. Mr. Segars has served as ARMs Chief Executive Officer since July 2013 and as a member of its board of directors since 2005. Mr. Segars also has served as a member of SoftBank Group Corporationrations board of directors since June 2017. He served as President of ARM in 2013 before being promoted to Chief Executive Officer. Mr. Segars held the position of Executive Vice President and General Manager, Physical IP Division, from 2007 to 2012. Prior senior roles at ARM include Executive Vice President, Engineering Executive Vice President, Worldwide Sales and Executive Vice President, Business Development. Mr. Segars worked on many of the early ARM CPU products and led the development of the ARM7 and ARM9 Thumb families. He holds a number of patents in the field of embedded CPU architectures since 2015.
| Age | 52 |
| Tenure | 9 years |
| Address | 1275 Market Street, San Francisco, CA, United States, 94103-1410 |
| Phone | 415 558 0200 |
| Web | https://www.dolby.com |
Dolby Laboratories Management Efficiency
The company has Return on Asset of 0.0531 % which means that on every $100 spent on assets, it made $0.0531 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0815 %, implying that it generated $0.0815 on every 100 dollars invested. Dolby Laboratories' management efficiency ratios could be used to measure how well Dolby Laboratories manages its routine affairs as well as how well it operates its assets and liabilities. At present, Dolby Laboratories' Return On Tangible Assets are projected to slightly decrease based on the last few years of reporting. The current year's Return On Assets is expected to grow to 0.12, whereas Return On Capital Employed is forecasted to decline to 0.08. At present, Dolby Laboratories' Non Currrent Assets Other are projected to increase significantly based on the last few years of reporting. The current year's Other Assets is expected to grow to about 358.1 M, whereas Total Assets are forecasted to decline to about 2 B.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Russell Beliveau | Maximus | 70 | |
| Benaree Wiley | CBIZ Inc | 74 | |
| Joshua Weisenbeck | BrightView Holdings | 38 | |
| Paul Lederer | Maximus | 78 | |
| Wellington Webb | Maximus | 74 | |
| Wayne Grace | Cass Information Systems | 73 | |
| Sherrill Hudson | CBIZ Inc | 78 | |
| Randall Schilling | Cass Information Systems | 55 | |
| Sydney Carey | BrightView Holdings | 51 | |
| Franklin Wicks | Cass Information Systems | 64 | |
| Emanuel Pearlman | Network 1 Technologies | 57 | |
| Gina France | CBIZ Inc | 62 | |
| Stephen Pirnat | AZZ Incorporated | 66 | |
| Richard Roedel | BrightView Holdings | 71 | |
| Cesare Fazari | First Advantage Corp | N/A | |
| David Kahn | Network 1 Technologies | 65 | |
| Michael Warren | Maximus | 53 | |
| Paul Eisman | AZZ Incorporated | 64 | |
| Gayathri Rajan | Maximus | 53 | |
| Joseph DiMartino | CBIZ Inc | 77 | |
| Ralph Clermont | Cass Information Systems | 70 | |
Management Performance
| Return On Equity | 0.0815 | ||||
| Return On Asset | 0.0531 |
Dolby Laboratories Leadership Team
Elected by the shareholders, the Dolby Laboratories' board of directors comprises two types of representatives: Dolby Laboratories inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Dolby. The board's role is to monitor Dolby Laboratories' management team and ensure that shareholders' interests are well served. Dolby Laboratories' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Dolby Laboratories' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Ioan Allen, Senior President | ||
| N Jasper, Independent Director | ||
| Maggie ODonnell, Head Relations | ||
| Giles Baker, Senior Vice President Consumer Entertainment | ||
| Ryan Nicholson, VP Controller | ||
| Linda Rogers, Senior Officer | ||
| Andy Sherman, General VP | ||
| Robert Park, Chief Financial Officer, Senior Vice President | ||
| Craig Todd, CTO VP | ||
| Avadis Tevanian, Independent Director | ||
| Simon Segars, Independent Director | ||
| Steven Forshay, Senior Vice President - Advanced Technology Group | ||
| David Dolby, Independent Director | ||
| Elena Carr, Director of Investor Relations | ||
| Doug Darrow, Senior Group | ||
| Peter Gotcher, Independent Chairman of the Board | ||
| Peter Goldmacher, Vice Relations | ||
| John Couling, Senior Entertainment | ||
| NWilliam Jasper, Independent Director | ||
| Todd Pendleton, Senior Vice President Chief Marketing Officer | ||
| Roger Siboni, Independent Director | ||
| Michael Bergeron, Sr. VP of Worldwide Sales and Field Operations | ||
| Lewis Chew, Chief Financial Officer, Executive Vice President | ||
| Bob Borchers, Senior Vice President Chief Marketing Officer | ||
| Mark Sherman, Executive Vice President General Counsel, Corporate Secretary | ||
| Nicholas Donatiello, Independent Director | ||
| Anjali Sud, Independent Director | ||
| Micheline Chau, Independent Director | ||
| Robert Borchers, Chief Marketing Officer and Sr. VP | ||
| Kevin Yeaman, CEO and President Director and Member of Stock Plan Committee | ||
| Tony Prophet, Independent Director | ||
| Emily Rollins, Independent Director | ||
| Sanford Robertson, Independent Director |
Dolby Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Dolby Laboratories a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0815 | ||||
| Return On Asset | 0.0531 | ||||
| Profit Margin | 0.15 % | ||||
| Operating Margin | 0.23 % | ||||
| Current Valuation | 6.8 B | ||||
| Shares Outstanding | 59.49 M | ||||
| Shares Owned By Insiders | 1.49 % | ||||
| Shares Owned By Institutions | 96.49 % | ||||
| Number Of Shares Shorted | 1.44 M | ||||
| Price To Earning | 23.36 X |
Pair Trading with Dolby Laboratories
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Dolby Laboratories position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dolby Laboratories will appreciate offsetting losses from the drop in the long position's value.Moving together with Dolby Stock
| 0.75 | HPQ | HP Inc Sell-off Trend | PairCorr |
Moving against Dolby Stock
| 0.42 | BHE | Benchmark Electronics Earnings Call This Week | PairCorr |
The ability to find closely correlated positions to Dolby Laboratories could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Dolby Laboratories when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Dolby Laboratories - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Dolby Laboratories to buy it.
The correlation of Dolby Laboratories is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Dolby Laboratories moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Dolby Laboratories moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Dolby Laboratories can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dolby Laboratories. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. For information on how to trade Dolby Stock refer to our How to Trade Dolby Stock guide.You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Complementary Tools for Dolby Stock analysis
When running Dolby Laboratories' price analysis, check to measure Dolby Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dolby Laboratories is operating at the current time. Most of Dolby Laboratories' value examination focuses on studying past and present price action to predict the probability of Dolby Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dolby Laboratories' price. Additionally, you may evaluate how the addition of Dolby Laboratories to your portfolios can decrease your overall portfolio volatility.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |
Is Dolby Laboratories' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dolby Laboratories. If investors know Dolby will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dolby Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.16) | Dividend Share 1.14 | Earnings Share 1.92 | Revenue Per Share 13.388 | Quarterly Revenue Growth (0.06) |
The market value of Dolby Laboratories is measured differently than its book value, which is the value of Dolby that is recorded on the company's balance sheet. Investors also form their own opinion of Dolby Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Dolby Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dolby Laboratories' market value can be influenced by many factors that don't directly affect Dolby Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dolby Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if Dolby Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dolby Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.